@AJWPharm I wish it was just 1 fix! Increasing Rx awareness of tube status in verification/workup was 1, other ideas sidelined a bit w/ COVID were conditional alerts on MAR, flagging pts with mix of enteral/PO meds, alert on 'okay to use tube' order listing pt meds that may need changing..
So rewarding to see my PGY1 research project @MayoPharmRes finally in print! See what we found about the growth of cystatin C at a high-volume center and testing availability throughout the state of MN!
So pleased to have this paper out.
Signif inc in nonprotocolized use, espesh in the ICU. Discordance between eGFRcr and eGFRcys inpt >>> outpt, Qualitative data to come.
https://t.co/PbhNcmdjOH
@MayoProceedings@pwierusz@HilaryTea4@jaykoyner@womeninnephro@NephJC
Congratulations to my residency research mentor @erin_barreto for this amazing accomplishment! I am so grateful for the past two years of learning and inspiration!
The three shields of @MayoClinic are education, practice, and research. MICU preceptor @erin_barreto has been awarded a prestigious @NIAIDFunding K23 grant, making her the first pharmacist in our department to receive federal funding to support her work advancing the third shield